Looking back on the Women In Procurement Panel at Procurement & Supply Chain LIVE Chicago, featuring guests from HH Global, ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...

The keen interest from Big Pharma has also excited the stock market. After the Otsuka deal was announced, HBM's share price ...

On June 5–6, the Global Think-tank on Steatotic Liver Disease1 convened a multidisciplinary group of 125 participants in Barcelona, including clinicians, patient advocates, public health experts, and ...

AstraZeneca R&D is contributing SEK 100 million and the University ... The professorship is the latest building block that we, together with the parties involved, are now adding.” ...

AstraZeneca announced that it has entered into a strategic research collaboration with CSPC Pharmaceutical Group to accelerate the discovery and development of novel oral therapies using artificial ...

In April, AstraZeneca entered into a three-way partnership with Tempus AI and Pathos , with $200 million in data licensing, to build a multimodal AI oncology model. “This is about building those data ...

Smile Group, a technology investor and operator, has appointed Gagandeep Singh Bedi, former managing director at AstraZeneca Pharma India, as managing partner to lead its new healthtech venture ...

(Alliance News) - AstraZeneca PLC on Friday said it has received positive data from a trial evaluating Imfinzi as a treatment for patients with high-risk non-muscle-invasive bladder cancer. The ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to attack cancer.

AstraZeneca PLC (NASDAQ: AZN) Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ET Company Participants Andy Barnett - Head of IR Pascal Soriot - Executive Director and CEO Aradhana Sarin ...